Sponsor or institution
Clinical trials and research at Huashan Hospital
As of November 12, 2026, Find a Trial lists 57 clinical trials run by Huashan Hospital that are recruiting, in China. 1 was first registered in the last 30 days. By phase: Phase 3 (6), Phase 2 (6), Phase 4 (3), Phase 2/3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 57Clinical trials
- 1New in 30 days
- 1Country
Newest trials
All recruiting trials (57)
-
Short-Course TB Treatment for Children with Non-Severe Pulmonary TB
This trial tests two shorter-treatment options for kids with non-severe pulmonary TB to see if they can clear the infection as well as the standard 6-month plan.
-
Niaoduqing Granules for Older Adults with Kidney Function Decline
This study tests whether Niaoduqing Granules can slow kidney decline and improve nutrition and frailty in adults over 60 with non-dialysis chronic kidney disease.
-
Enarodustat for Anemia in Non-Dialysis CKD Patients
This study tests whether enarodustat can help increase hemoglobin safely in adults with CKD who aren’t on dialysis, grouping participants by inflammation level.
-
Gastric and pancreatic cancer patients see if IR199 with Ga-68 and I-131 is safe and how it distributes in the body
This study tests the safety and how the radio-labeled IR199 distributes in the body of adults with Claudin 18.2-positive gastric or pancreatic cancer.
-
Clinical Multimodal Surveillance of Respiratory Pathogens
This nationwide study tests a hospital-based system to track respiratory pathogens in patients with respiratory symptoms and to use samples collected during care to spot trends and support prevention efforts.
-
Infection and Immune Aging in Older Adults: A Look at How Immunosenescence Relates to Infections
This study will follow people aged 60 and up to see how aging immune systems relate to infections, comparing healthy seniors with those who have infections.
-
How urban stress patterns relate to mental illness in adults
This study tests whether real-time environmental stress in cities is linked to depression, anxiety, or alcohol use disorders in adults 18–60 who wear a wrist sensor and use a study app.
-
YSCH-01 alone or with atezolizumab for recurrent glioblastoma
This will test whether YSCH-01 by itself or together with atezolizumab helps people with recurrent glioblastoma live longer.
-
Empagliflozin to improve left atrial function in people with paroxysmal atrial fibrillation, hypertension, and abnormal glucose metabolism
This trial tests whether taking empagliflozin once daily for 12 months can improve left atrial function in adults with paroxysmal atrial fibrillation, hypertension, and diabetes or prediabetes.
-
Probiotics to improve bowel function after ileostomy reversal for ultra‑low rectal cancer
This trial tests whether placing a probiotic (Clostridium butyricum) into the diverted distal bowel before stoma reversal helps people who had intersphincteric resection and a temporary ileostomy recover better bowel function.
-
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
In this study, adults with newly diagnosed primary CNS lymphoma try different induction regimens to see which one works best before consolidation therapy.
-
Shanghai registry of ischemic stroke with focus on younger adults
This project will collect medical and imaging information from adults in Shanghai who had an imaging-confirmed ischemic stroke to see what causes, risk factors, treatments, and outcomes look like, with extra focus on people under 55.
-
Multimodal digital assessment for myasthenia gravis.
This project will try a multimodal digital system using facial and eye-movement videos, speech and limb motion recordings, and physiological sensors to see if it can measure symptom severity in adults with myasthenia gravis.
-
Colchicine to prevent repeat lobar brain bleeds from cerebral amyloid angiopathy
This trial will test whether taking a daily low-dose colchicine pill for a year is safe and helps prevent repeat lobar intracerebral hemorrhage in people with cerebral amyloid angiopathy who are at high risk of another bleed.
-
Tenecteplase for ischemic stroke given after 4.5 hours when CT shows a small infarct
This trial will try whether a single 0.25 mg/kg dose of tenecteplase helps adults with anterior-circulation ischemic stroke who present more than 4.5 hours after last known well and whose non-contrast CT shows limited infarction.
-
Treatment of gout using potassium citrate tablets
This study is testing if potassium citrate and sodium bicarbonate can help people with gout lower their uric acid levels and reduce flare-ups while also preventing kidney stones.
-
Flow-diverter treatment for brain aneurysms: safety and effectiveness
This project will try a flow-diverter device to see if it safely closes brain aneurysms in adults.
-
Sequential PEG-IFN for Hepatitis B After RNA-targeted Therapy
This study tests whether starting or delaying a 24-week course of pegylated interferon helps people with chronic hepatitis B who previously used ASO/siRNA therapies.
-
Using deep brain stimulation to treat Meige syndrome
This study is testing a new deep brain stimulation method to see if it can help people with Meige syndrome improve their movement and overall quality of life.
-
Satralizumab in NMOSD: Real-world outcomes from China
This study looks at how satralizumab works for Chinese patients with NMOSD in everyday clinical care by following people over time.
-
Establishing a cohort for Alzheimer's disease research in China
This study is trying to understand how brain scans and other health markers relate to Alzheimer's disease in both people with and without cognitive issues in China, to help find ways to detect and prevent the disease early.
-
Comparing obinutuzumab to cyclophosphamide and glucocorticoids for treating primary membranous nephropathy
This study is testing if a new drug called obinutuzumab works just as well as the standard treatment of cyclophosphamide and glucocorticoids for people with primary membranous nephropathy.
-
Using Propranolol for Patients with Gastrointestinal Tumors Before Surgery
This study is testing if giving propranolol, a beta-blocker, to patients with gastrointestinal tumors before surgery can help reduce stress and improve outcomes.
-
Patient-derived organoid drug sensitivity testing for recurrent or metastatic salivary gland cancer
This project will test whether drugs that kill a patient’s tumor cells in lab-grown organoids match which systemic treatments help people with recurrent or metastatic salivary gland cancer.
-
Patient-derived organoid drug sensitivity testing for recurrent/metastatic head and neck cancer
This project will test whether drug-sensitivity results from a patient's tumor-derived organoids predict which systemic treatments work best for people with recurrent or metastatic head and neck cancer.
-
New surgical technique for gastric cancer treatment
This study is testing a new surgical method for gastric cancer to see if it helps patients recover better and have improved nutrition compared to the traditional surgery.
-
Comparing neck observation and elective neck dissection for early-stage oral cancer
This study is testing whether watching the neck or doing surgery to remove lymph nodes is better for people with early-stage oral cancer in terms of survival and quality of life.
-
Evaluating two methods for diagnosing MOG-antibody related disorders
This study is testing two different lab methods to see which one is better at diagnosing MOG-antibody related disorders in people who might have them.
-
Using AI tools to improve diagnosis of respiratory infections through medical imaging
This study is testing whether using artificial intelligence with medical imaging can help doctors diagnose respiratory infections like pneumonia more accurately and quickly.
-
Detecting HBsAg Reversion in Hepatitis B Patients
This study is testing how well a new blood test can find if hepatitis B patients who have stopped treatment might have their virus levels come back after being cleared.
-
Evaluating spinal cord stimulation for patients with disorders of consciousness
This study is testing whether spinal cord stimulation can help people with disorders of consciousness from brain injuries become more alert and aware.
-
Using body posture to prevent recurrence of chronic subdural hematoma after surgery
This study is testing if certain sleeping positions can help prevent chronic subdural hematomas from coming back after surgery.
-
Using Ketosteril to Improve Muscle Loss in Kidney Disease Patients
This study is testing if adding Ketosteril to a low-protein diet can help people with chronic kidney disease build muscle and improve strength without harming their kidneys.
-
Innovative surgical technique for treating gastric cancer
This study is testing a new surgical technique for treating gastric cancer to see if it is safe and helps patients recover better after surgery.
-
Neoadjuvant immunochemotherapy for advanced oral cancer
This study is testing a new combination of immunotherapy and chemotherapy to see if it can shrink tumors in people with advanced oral cancer before they have surgery, and if it helps them live longer compared to standard treatments.
-
Registry for patients with Myasthenia Gravis in China
This study is creating a national registry for people with Myasthenia Gravis in China to track their health and treatment over ten years.
-
Combining Human Urinary Kallidinogenase with Endovascular Therapy for Acute Ischemic Stroke
This study is testing if adding a new treatment called Human Urinary Kallidinogenase to standard endovascular therapy can help people who have had a severe stroke caused by a blocked blood vessel.
-
Investigating B7-H4's Role in Glioma Vaccine Response
This study is trying to see how a protein called B7-H4 affects the response to cancer vaccines in people with glioma to help find better treatment options.
-
Shortened treatment options for people with asymptomatic pulmonary TB
This project tests whether people with bacteriologically confirmed but symptom-free pulmonary tuberculosis can be treated safely with a 17-week standard-drug course or a 13-week high-dose rifapentine plus moxifloxacin course instead of the longer standard regimen.
-
Tumor vaccines for treating glioma and solid tumors
This study is testing whether a new type of vaccine made from immune cells can help people with brain tumors live longer and feel better.
-
Treatment of brainstem cavernous malformations with sirolimus
This study is testing if the drug sirolimus can help people who have had bleeding in the brain due to brainstem cavernous malformations by reducing the chances of more bleeding.
-
Neoadjuvant treatment for locally advanced gastric cancer using Sintilimab and chemotherapy
This study is testing if a new combination of a drug called Sintilimab and chemotherapy can help people with locally advanced stomach cancer before surgery and improve their chances of recovery.
-
Screening for latent tuberculosis in school contacts of active patients
This study is testing how common tuberculosis infection is among students aged 13 and older who have been in close contact with active tuberculosis patients to improve screening methods in schools.
-
One-month treatment for latent tuberculosis in school contacts
This study is testing if a one-month treatment for latent tuberculosis can help protect school-aged kids who have been in close contact with someone who has TB.
-
New diagnostic strategy for respiratory infections in fever clinics
This study is testing a new way to quickly diagnose respiratory infections in patients with fever and cough to help doctors provide better care.
-
Observing antiviral treatment strategies for chronic hepatitis B in real-world settings
This study looks at how well different antiviral treatments for chronic hepatitis B work in everyday medical settings for adults aged 18 to 80.
-
Combination treatment for relapse refractory central nervous system lymphoma
This study is testing a new combination of three medications to see if it can help people with hard-to-treat central nervous system lymphoma feel better.
-
Optimizing rifapentine treatment for drug-sensitive tuberculosis
This study is testing a higher dose of rifapentine to see if it can effectively treat drug-sensitive tuberculosis in just 17 weeks, making it easier for patients to stick to their treatment.
-
Evaluating Paxlovid for treating hospitalized COVID-19 patients
This study is testing how well Paxlovid works and its safety for people hospitalized with COVID-19 by looking at their medical records.
-
New all-oral treatment for rifampicin-resistant tuberculosis
This study is testing seven new all-oral treatment options for people with rifampicin-resistant tuberculosis to see if they work better than the standard treatment.
-
Long-term outcomes of antiviral therapies for chronic hepatitis B
This study is testing how well two different antiviral treatments for chronic hepatitis B work over five years to see if they help prevent serious liver problems.
-
Improving diagnosis and understanding of myasthenia gravis in Chinese patients
This study is trying to improve how doctors diagnose and understand myasthenia gravis in Chinese patients by tracking the health of 300 people with the condition over time.
-
Factors affecting brain health in hemodialysis patients
This study looks at how different factors affect brain health in people aged 50 to 85 who have been on hemodialysis for over three months.
-
Exploring end-stage liver disease in China
This study looks at how end-stage liver disease is currently being diagnosed and treated in China to see if better methods can help patients with liver cirrhosis and its complications.
-
Collecting data on chronic viral hepatitis patients
This study is trying to collect information from people with chronic viral hepatitis to better understand their long-term health and improve treatment options.
-
Observational study on classic infectious diseases
This study looks at samples from patients with classic infectious diseases like brucellosis and kala-azar in China to see how common they are and what treatments work best.
-
National Registry for Patients with Parkinsonian Disorders in China
This study is creating a registry using a mobile app to collect health information from people with Parkinsonian disorders in China to help improve understanding and communication about their condition.
Quick answers
How many clinical trials run by Huashan Hospital are recruiting right now?
57, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 6, Phase 2: 6, Phase 4: 3, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.